![Carol Gallagher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carol Gallagher
Director/Board Member at
TREX BIO, INC.
Net worth: 4 M $ as of 2026-09-29
Profile
Dr. Carol G.
Gallagher is an Independent Director at PMV Pharmaceuticals, Inc. and an Executive Chairman at TRex Bio, Inc. She is on the Board of Directors at PMV Pharmaceuticals, Inc., Xoc Pharmaceuticals, Inc., Millendo Therapeutics US, Inc., Certara Holdings, Inc., Recludix Pharma, Inc. and Sanford Burnham Prebys Medical Discovery Institute.
Dr. Gallagher was previously employed as an Independent Director by Mirati Therapeutics, Inc., an Independent Director by Certara, Inc., an Independent Director by Frazier Lifesciences Acquisition Corp., an Independent Director by Turning Point Therapeutics, Inc., a Chairman by ChromaCode, Inc., an Independent Director by Metacrine, Inc., a Venture Advisor by NEA Management Co. LLC, a Partner by New Enterprise Associates LLC, a Venture Partner by Frazier Management LLC, a Lead Independent Director by Atara Biotherapeutics, Inc., a Chairman by eFFECTOR Therapeutics Operations, Inc., an Independent Director by AnaptysBio, Inc., a President & Chief Executive Officer by Calistoga Pharmaceuticals, Inc., a President & Chief Executive Officer by Metastatix, Inc., a SVP-Corporate Development & Commercial Affairs by Anadys Pharmaceuticals, Inc., a Vice President-Product Planning by CancerVax Corp., a Senior Director-Oncology Marketing by Biogen Idec, Inc., a Vice President-Sales & Marketing by Amgen, Inc., a Vice President-Sales & Marketing by Eli Lilly & Co., a Vice President-Sales & Marketing by Agouron Pharmaceuticals LLC, a Rituxan Development Team Leader by IDEC Pharmaceuticals Corp., an Independent Director by OncoResponse, Inc., and a Director-Global Marketing Planning by Pfizer Inc..
She received her undergraduate degree from the University of Kentucky College of Pharmacy and a doctorate degree from the University of Kentucky College of Pharmacy.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TREX BIO, INC. 0.92% | 2026-10-08 | 251,471 ( 0.92% ) | 4 M $ | 2026-09-29 |
| 2026-03-09 | 25,184 ( 0.25% ) | 214 064 $ | 2026-09-29 | |
| 2026-06-03 | 0 ( -.--% ) | - $ | 2026-09-29 |
Carol Gallagher active positions
| Companies | Position | Start |
|---|---|---|
| TREX BIO, INC. | Director/Board Member | 2025-12-31 |
| PMV PHARMACEUTICALS, INC. | Director/Board Member | 2022-11-02 |
Xoc Pharmaceuticals, Inc.
 Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel oral therapies for migraine prevention and dopamine agonism parkinson’s disease management | Director/Board Member | 2018-09-30 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Director/Board Member | - |
Certara Holdings, Inc.
 Certara Holdings, Inc. Packaged SoftwareTechnology Services Develops software for clinical pharmacology | Director/Board Member | - |
Sanford Burnham Prebys Medical Discovery Institute
 Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Conducts medical research | Director/Board Member | - |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Director/Board Member | 2012-08-31 |
Former positions of Carol Gallagher
| Companies | Position | End |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Chairman | 2024-09-08 |
| MIRATI THERAPEUTICS | Director/Board Member | 2024-01-22 |
| ░░░ ░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Education of Carol Gallagher
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
39
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 39 |
|---|---|
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Health Technology |
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
CancerVax Corp.
 CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Commercial Services |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Metastatix, Inc.
 Metastatix, Inc. Pharmaceuticals: MajorHealth Technology Develops small moleclue drugs | Health Technology |
Calistoga Pharmaceuticals, Inc.
 Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes targeted immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Sharp HealthCare
 Sharp HealthCare Hospital/Nursing ManagementHealth Services Operates acute care and specialty hospitals | Health Services |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Conducts medical research | Health Services |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. BiotechnologyHealth Technology Operates a clinical-stage biopharmaceutical company that develops oncology drugs | Health Technology |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
University of Kentucky College of Pharmacy
 University of Kentucky College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Metacrine, Inc.
 Metacrine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
OncoResponse, Inc.
 OncoResponse, Inc. Pharmaceuticals: MajorHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Health Technology |
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-based Immuno-oncology therapeutics | Health Technology |
ChromaCode, Inc.
 ChromaCode, Inc. Packaged SoftwareTechnology Services Develops software and manufactures laboratory instruments | Technology Services |
Xoc Pharmaceuticals, Inc.
Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel oral therapies for migraine prevention and dopamine agonism parkinson’s disease management | Commercial Services |
Qpex Biopharma, Inc.
 Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery, development and regulatory services for clinical-stage biopharmaceutical company | Health Technology |
New Enterprise Associates LLC
 New Enterprise Associates LLC Investment ManagersFinance Operates as a venture capital firm | Finance |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Trex Bio, Inc.
 Trex Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that engages in autoimmune and inflammatory disease discovery activities | Health Technology |
Certara, Inc.
 Certara, Inc. Packaged SoftwareTechnology Services Develops bio simulation software and technology to transform traditional drug discovery and development | Technology Services |
Frazier Lifesciences Acquisition Corp.
 Frazier Lifesciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Certara Holdings, Inc.
Certara Holdings, Inc. Packaged SoftwareTechnology Services Develops software for clinical pharmacology | Technology Services |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
- Stock Market
- Insiders
- Carol Gallagher
